Mariner’s CareDx CDNA Stock Holding History

Mariner’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Sell	14,293 -3,674	-20%	-$80K	﹤0.01%	2605
2026 Q1	$312K	Buy	+17,967	New	+$340K	﹤0.01%	2834

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mariner's CDNA Position: Q2 2026 in Review

Mariner reduced its CareDx (CDNA) stake by 20% in Q2 2026, selling an estimated $80K and leaving 14,293 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Mariner first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Mariner held 14,293 shares of CareDx worth $407K as of Q2 2026.
Mariner sold 3,674 CareDx shares in Q2 2026, an estimated $80K.
CareDx made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2605 holding.
Mariner first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.